NASDAQ:BCRX

BioCryst Pharmaceuticals Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$4.45

-0.0300 (-0.670%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for BCRX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	4.76	7.04 %
		R2	4.67	4.90 %
		R1	4.61	3.57 %
Current price:			4.45
	Support	S1	4.42	-0.723 %
		S2	4.36	-2.05 %
		S3	4.26	-4.19 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	5.32	19.55 %
		R2	5.14	15.51 %
		R1	5.00	12.36 %
Current price			4.45
	Support	S1	4.43	-0.449%
		S2	4.38	-1.57%
		S3	4.16	-6.52%

BCRX Predictions History

7 years ago
JS predicted that BCRX for 2017-04-13 is going $6.70 (-0.74%)

7 years ago
JuanC Villegas predicted that BCRX for 2017-04-13 is going $7.27 (6.75%)

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In